Dopamine/norepinephrine/phenylephrinePosterior reversible encephalopathic syndrome: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1718卷 / 1期

关键词：

D O I：

10.1007/s40278-018-51443-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：99 / 99

相关论文

共 50 条

[1] Norepinephrine/phenylephrinePosterior reversible encephalopathy syndrome: 5 case reports
Reactions Weekly, 2020, 1801 (1) : 202 - 202
[2] PhenylephrinePosterior reversible encephalopathy syndrome with haemorrhagic conversion: 2 case reports
Reactions Weekly, 2020, 1828 (1) : 423 - 423
[3] PhenylephrinePosterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2021, 1839 (1) : 257 - 257
[4] Dopamine/norepinephrine/prednisolonePosterior reversible encephalopathy syndrome and lack of efficacy: case report
Reactions Weekly, 2020, 1812 (1) : 101 - 101
[5] AsparaginasePosterior reversible encephalopathy syndrome: 3 case reports
Reactions Weekly, 2008, 1213 (1) : 10 - 10
[6] TacrolimusPosterior reversible encephalopathy syndrome: 3 case reports
Reactions Weekly, 2014, 1511 (1) : 41 - 41
[7] TACROLIMUS INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHIC SYNDROME
Liaqat, Aimen
Amin, Saad
AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 696 - 697
[8] Multiple drugsPosterior reversible encephalopathy syndrome: 3 case reports
Reactions Weekly, 2024, 2027 (1) : 344 - 344
[9] Dopamine/phenylephrine/propofolPropofol infusion syndrome: 3 case reports
Reactions Weekly, 2009, 1260 (1) : 14 - 14
[10] Dopamine-receptor-agonistsOthello syndrome: 3 case reports
Reactions Weekly, 2017, 1681 (1) : 141 - 141

← 1 2 3 4 5 →